Sai Parenterals Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sai Parenterals Ltd is ₹ 486.4 as of 30 Apr 15:30 . The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 .The P/E Ratio of Sat Kartar Shopping Ltd is 0 as of March 2023 . The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sat Kartar Shopping Ltd is ₹ 0 crore as of March 2023 . The Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Sat Kartar Shopping Ltd changed from 3.11 % on March 2024 to 11.22 % on March 2025 . This represents a CAGR of 89.94% over 2 years .

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

About Sat Kartar Shopping Ltd

Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of 'Sat Kartar Shopping Private Limited' vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi.
Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
Manprit Singh Chadha is the Promoter of the Company. Sat Kartar Shopping is an Ayurveda healthcare company committed to providing natural wellness solutions relating to specific therapeutic areas and general lifestyle products, committed to promote a healthier lifestyle.
It integrate traditional Ayurvedic knowledge with modern research to empower individuals to adopt healthier lifestyles.

FAQs for the comparison of Sai Parenterals Ltd and Sat Kartar Shopping Ltd

Which company has a larger market capitalization, Sai Parenterals Ltd or Sat Kartar Shopping Ltd?

Market cap of Sai Parenterals Ltd is 2,148 Cr while Market cap of Sat Kartar Shopping Ltd is 308 Cr

What are the key factors driving the stock performance of Sai Parenterals Ltd and Sat Kartar Shopping Ltd?

The stock performance of Sai Parenterals Ltd and Sat Kartar Shopping Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sai Parenterals Ltd and Sat Kartar Shopping Ltd?

As of May 4, 2026, the Sai Parenterals Ltd stock price is INR ₹486.4. On the other hand, Sat Kartar Shopping Ltd stock price is INR ₹195.85.

How do dividend payouts of Sai Parenterals Ltd and Sat Kartar Shopping Ltd compare?

To compare the dividend payouts of Sai Parenterals Ltd and Sat Kartar Shopping Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.